Overview

Global Sleep Apnea Devices Market is estimated to value over USD 6 billion by 2026 end CAGR of over 10% during the forecast period from 2019 to 2026.

The rising prevalence of sleep disorders in the global population is one of the main factors driving the growth of the global sleep apnea devices market. The rising geriatric population due to improved medical procedures also increases cases of sleep disorders and ailments among the population. According to the Sleep Apnea Organization, more than 22 million Americans experience sleep apnea disorder and 80% of moderate to severe sleep apnea cases were undiagnosed. On a global scale, over 100 million people collectively suffer from sleep apnea. Thus, the growing prevalence of sleep apnea as a major disorder affecting the majority of the population is one of the factors responsible for the growth of the sleep apnea devices market.

Obstructive sleep apnea (OSA) is a prevalent ailment, which affects about 20% of the world population, thus demanding medical solutions and remedies in high numbers. It is a chronic and fatal sleep sickness that is widely undiagnosed and overlooked. However, various government initiatives are benefiting patients by raising awareness about OSA. For instance, in the United States, the American Sleep Apnea Association (ASAA) was founded in 1990, advances awareness regarding sleep apnea, advocates for sustainable developments in therapies for this severe complication, and works in the interest of the patients. The factors, such as heightened occurrences of sleep apnea, growing consciousness among the patient population in the developing countries, favorable government initiatives, and forthcoming technological advancements, are expected to drive the growth of the market over the forecast period.

An increasingly sedentary lifestyle with serious alterations leading to grave side-effects, resulting in cardiovascular disease, erratic sleep patterns, and high frequencies of stress and obesity, will continue to boost the industry's development. All of these factors increase the prevalence of sleep apnea. The inadequacy of patient conformity and significant healthcare costs are predicted to restrict the development of the market.

Advances in technology to improve sleep apnea devices have led to the growth of a range of standard sleep apnea therapies. Moreover, continuous efforts both in private and public sectors to develop efficient equipment and cures, raise global demand. The untapped potential in emerging countries will expand the market over the forecast period. Raised consciousness and a positive reimbursement scenario will improve the adoption rate.

North America led the global market with the largest market share. An extensive patient pool and the presence of established manufacturers helps the growth of the market and is further anticipated to augment the regional demand. Rising concerns regarding health risks arising out of sleep apnea is promoting the market growth. Technological improvements in diagnostic and therapeutic devices and accessibility of products like the Elastic Mandibular Advancements (EMA), is another factor promoting the regional revenue growth.

The Asia Pacific is projected to be the fastest-growing market over the forecast period. A large patient pool with an increasing number of clinics is anticipated to promote robust growth. Manufacturers are concentrating on fabricating policies towards enhancing their customer base through the introduction of affordable devices for price-sensitive customers in the Asia Pacific.

Sleep Apnea Devices Market is majorly occupied by firms such as BMC Medical Co. Ltd; GE Healthcare; Fisher & Paykel Healthcare Limited; Curative Medical Inc.; Cadwell Laboratories; ResMed; Invacare Corporation; Braebon Medical Corporation; ImThera Medical Inc.; Philips Respironics; Curative Medical Inc.; Nihon Kohden; and Compumedics Limited. The market is oligopolistic in nature with companies like ResMed, Fisher & Paykel, Philips Respironics, and CareFusion capturing about 90.0% of total market share.

Market Segmentation

By Type

• Therapeutic Devices
• Positive Airway Pressure Devices
• Automatic Positive Airway Pressure Devices
• Continuous Positive Airway Pressure Devices
• Bilevel Positive Airway Pressure Devices
• Facial Interfaces
• Masks
• Full-Face Masks
• Nasal Pillow Masks
• Nasal Masks
• Cushions
• Accessories
• Oral Appliances
• Mandibular Advancement Devices
• Tongue-Retaining Devices
• Adaptive Servo-Ventilators
• Other Therapeutic Devices
• Diagnostic Devices
• Polysomnography Devices
• Ambulatory PSG Devices
• Clinical PSG Devices
• Home Sleep Testing Devices
• Oximeters
• Fingertip Oximeters
• Handheld Oximeters
• Wrist-Worn Oximeters
• Tabletop Oximeters
• Actigraphy Systems
• Sleep Screening Devices

By End User

• Sleep Laboratories & Hospitals
• Home Care Settings/Individuals

By Region

• Europe
• North America
• APAC
• Latin America
• Rest of World

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants 

FutureWise Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data points affecting market growth

Objectives of the Study:

• To provide an exhaustive analysis on the global sleep apnea market by product type, by end-user, and by region
•  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•  To evaluate and forecast micro-markets and the overall market
•  To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world
•  To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•  Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction 

    1.1 Objectives of the Study 
    1.2 Market Definition 
    1.3 Market Scope 
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency 
    1.5 Limitations 
    1.6 Stakeholders 

2 Research Methodology
    2.1 Research Data 
           2.1.1 Secondary and Primary Research Methodology
                    2.1.1.1 Secondary Research
                               2.1.1.1.1 Key Data From Secondary Sources
                    2.1.1.2 Primary Research
                               2.1.1.2.1 Key Data From Primary Sources
                               2.1.1.2.2 Key Insights From Primary Sources
           2.1.2 Market Size Estimation Methodology
    2.2 Market Data Validation and Triangulation 
    2.3 Assumptions for the Study 

3 Executive Summary 

4 Premium Insights 
    4.1 Sleep Apnea Devices Market Overview 
    4.2 Sleep Apnea Devices Market, By Type, 2019 vs 2024 (USD Million) 
    4.3 Sleep Apnea Therapeutic Devices Market, By Type, 2019 vs 2024 (USD Million) 
    4.4 Sleep Apnea Devices Market Share, By End User (2019 vs 2024) 
    4.5 Geographical Snapshot of the Sleep Apnea Devices: Market 

5 Market Overview

    5.1 Introduction 
    5.2 Market Dynamics 
           5.2.1 Drivers
                    5.2.1.1 Large Pool of Undiagnosed Sleep Apnea Patients
                    5.2.1.2 Growing Awareness About the Ill Effects of Untreated Sleep Apnea
                    5.2.1.3 Growing Usage of Oral Appliances
                    5.2.1.4 Technological Advancements in Sleep Apnea Devices
                    5.2.1.5 Considerable Venture Capital Funding
                    5.2.1.6 Increasing Number of Companies Venturing Into the Sleep Apnea and Oral Appliances Markets
           5.2.2 Restraints
                    5.2.2.1 High Cost of CPAP Machines
                    5.2.2.2 Complex Referral Pathways and Long Waiting Periods
           5.2.3 Opportunities
                    5.2.3.1 Growing Demand for Home Healthcare
                    5.2.3.2 Increasing Focus on Telemedicine and Mhealth (Mobile Health)
           5.2.4 Challenges
                    5.2.4.1 Lack of Patient Compliance

6 Epidemiological Assessment of Sleep Apnea 
    6.1 Introduction 
    6.2 Epidemiological Assessment 
    6.3 Prescription Pattern Assessment 
    6.4 Adherence Assessment 

7 Alternate Therapies for Sleep Apnea 
    7.1 Introduction 
    7.2 Expiratory Positive Airway Pressure 
    7.3 Hypoglossal Nerve Stimulation 
    7.4 Oral Pressure Therapy 
    7.5 Positional Therapy 

8 Sleep Apnea Devices Market, By Type 
    8.1 Introduction 
    8.2 Therapeutic Devices 
           8.2.1 Positive Airway Pressure Devices
                    8.2.1.1 PAP Devices Dominate the Therapeutic Devices Market
                               8.2.1.1.1 Automatic Positive Airway Pressure Devices
                               8.2.1.1.2 Continuous Positive Airway Pressure Devices
                               8.2.1.1.3 Bilevel Positive Airway Pressure Devices
           8.2.2 Facial Interfaces
                    8.2.2.1 Role of Facial Interfaces in Increasing CPAP Compliance is Expected to Drive Market Growth
                               8.2.2.1.1 Masks
                                             8.2.2.1.1.1 Full-Face Masks
                                             8.2.2.1.1.2 Nasal Pillow Masks
                                             8.2.2.1.1.3 Nasal Masks
                    8.2.2.2 Cushions
           8.2.3 Accessories
                    8.2.3.1 The Growth of the Accessories Segment is Tied to the Devices Market
           8.2.4 Oral Appliances
                    8.2.4.1 Advantages of Oral Appliances, Such as Comfort and Small Size, Have Driven Their Use
                               8.2.4.1.1 Mandibular Advancement Devices
                               8.2.4.1.2 Tongue-Retaining Devices
           8.2.5 Adaptive Servo-Ventilators
                    8.2.5.1 Studies Demonstrating the Significance of ASV in Improving Clinical Outcomes are Expected to Fuel Market Growth
           8.2.6 Other Therapeutic Devices
    8.3 Diagnostic Devices 
           8.3.1 Polysomnography Devices
                    8.3.1.1 PSG Tests are Considered the Gold Standard for the Diagnosis of Sleep-Related Breathing Disorders
                               8.3.1.1.1 Ambulatory PSG Devices
                               8.3.1.1.2 Clinical PSG Devices
           8.3.2 Home Sleep Testing Devices
                    8.3.2.1 Cost-Effectiveness of Home-Based Sleep Tests Expected to Fuel the Growth of Home Sleep Testing Devices
           8.3.3 Oximeters
                    8.3.3.1 Oximeters Help in Preoperative Monitoring and are Commonly Used in Clinics
                               8.3.3.1.1 Fingertip Oximeters
                               8.3.3.1.2 Handheld Oximeters
                               8.3.3.1.3 Wrist-Worn Oximeters
                               8.3.3.1.4 Tabletop Oximeters
           8.3.4 Actigraphy Systems
                    8.3.4.1 Increasing Focus on Assessing Actimeter Performance Will Contribute to Market Growth
           8.3.5 Sleep Screening Devices
                    8.3.5.1 Rising Preference for Home-Based Testing is Driving the Use of Sleep Screening Devices

9 Sleep Apnea Devices Market, By End User 
    9.1 Introduction 
    9.2 Sleep Laboratories & Hospitals 
           9.2.1 Increasing Number of Sleep Labs Globally to Drive the Growth of This End-User Segment
    9.3 Home Care Settings/Individuals 
           9.3.1 Rise in Preference of Patients and Insurance Companies for Home-Based Sleep Tests is Expected to Fuel Market Growth

10 Sleep Apnea Devices Market, By Region 
     10.1 Introduction 
     10.2 North America 
             10.2.1 US
                        10.2.1.1 US Dominated the North American Sleep Apnea Devices Market in 2018
             10.2.2 Canada
                        10.2.2.1 Rise in the Number of Grants Awarded to Research Organizations – A Major Factor Driving Market Growth in Canada
     10.3 Europe 
             10.3.1 Germany
                        10.3.1.1 The Prevalence of OSA in Germany is Among the Highest in Europe
             10.3.2 France
                        10.3.2.1 Rising Geriatric Population to Increase the Prevalence of Sleep Apnea in France
             10.3.3 UK
                        10.3.3.1 Increasing Number of Awareness Initiatives to Support Market Growth in the UK
             10.3.4 Italy
                        10.3.4.1 Government Initiatives for Improving Care for Sleep Apnea Patients to Drive Sleep Apnea Devices Market Growth in Italy
             10.3.5 Spain
                        10.3.5.1 Initiatives By Regional Organizations to Support Market Growth in Spain
             10.3.6 Rest of Europe
     10.4 Asia Pacific 
             10.4.1 Japan
                        10.4.1.1 Changing Reimbursement Scenario to Drive Market Growth in Japan
             10.4.2 China
                        10.4.2.1 Growing Adult Obesity Rates to Increase the Prevalence of Sleep Apnea in China
             10.4.3 Australia
                        10.4.3.1 Continuous Technological Advancements By Regional Players to Drive Market Growth in Australia
             10.4.4 RoAPAC
     10.5 Rest of the World 
     10.6 Latin America 
             10.6.1 Rising Obesity Rate to Increase the Prevalence of Sleep Apnea in Latam
     10.7 Middle East and Africa 
             10.7.1 Low Awareness About Sleep Apnea to Restrain Market Growth in the Middle East and Africa

11 Competitive Landscape

     11.1 Overview 
     11.2 Market Share Analysis 
             11.2.1 Introduction
     11.3 Competitive Leadership Mapping 
             11.3.1 Visionary Leaders
             11.3.2 Innovators
             11.3.3 Dynamic Differentiators
             11.3.4 Emerging Companies
     11.4 Competitive Scenario 
             11.4.1 Product Launches
             11.4.2 Acquisitions
             11.4.3 Partnerships, Agreements, and Collaborations

12 Company Profiles 
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, FutureWise View)*
     12.1 Resmed 
     12.2 Koninklijke Philips 
     12.3 Fisher & Paykel Healthcare 
     12.4 Somnomed 
     12.5 Oventus Medical 
     12.6 Compumedics 
     12.7 Löwenstein Medical 
     12.8 Drive Devilbiss Healthcare 
     12.9 BMC Medical 
     12.10 Braebon Medical Corporation 
     12.11 Whole You 
     12.12 Panthera Dental 

*Details on FutureWise View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

Tables

Figures